chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had experienced coughing like when she did when she had covid; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Had experienced coughing like when she did when she had covid) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In September 2021, the patient experienced COUGH (Had experienced coughing like when she did when she had covid). In September 2021, COUGH (Had experienced coughing like when she did when she had covid) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported. No treatment information was provided.  Patient had COVID back in December 2020 , did cold and flu medications for days and also had lingering effects from it including chest pain which happens randomly. She had an Electrocardiography (ECG), chest X ray (CXR), Computed tomography (CT) scans, and an Echo which was all normal prior to receiving the vaccine.   This case was linked to MOD-2021-339278 (Patient Link).
Arm is sore; Very bad stomach ache; Feel very weak; Not feeling well today; Have chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY, ABDOMINAL PAIN UPPER, ASTHENIA, MALAISE, and CHILLS in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.    Co-suspect product included non-company product Water for an unknown indication.    no medical history is provided and concomitant drugs are provided.  Concomitant products included PLAVIX for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started Water (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY, ABDOMINAL PAIN UPPER, ASTHENIA, MALAISE, and CHILLS. At the time of the report, PAIN IN EXTREMITY, ABDOMINAL PAIN UPPER, ASTHENIA, MALAISE, and CHILLS outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Rash at injection site that turned into hives on left arm, face, left side of neck, left side shoulder, abdomen, and legs. Started taking Benadryl 50mg, Pepcid 20 mg, Singulair, Hydrocortisone cream to arm from itching and open abrasions, and shot of Celestone from family MD.
full body blistering hives; full body blistering hives; eyes swollen shut; lips started to swell; This is a spontaneous report from a contactable consumer reported for herself.  A 18-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, in left arm on 26Mar2021 12:00, at the age of 18 years old (Batch/Lot Number: EN6208) as single dose for covid-19 immunisation, at the hospital. The patient had received the first dose of BNT162B2 on  05Mar2021 02:00 PM from lot # EN6200 in the left arm. Medical history included hypersensitivity. The patient's concomitant medications were not reported.  The patient was not pregnant. Patient had not Covid prior vaccination, patient has not tested positive for COVID-19 since having the vaccine. No Covid tested post vaccination. The patient experienced full body blistering hives, eyes swollen shut, lips started to swell on 27Mar2021 12:00 AM with outcome of recovering.  The patient was treated for the events with an injection of steroids and Benadryl at ER.   No follow up attempts are possible. No further information is expected.
I WAS GIVEN THE MODERNA BOOSTER SHOT ON 09/24/2021 THE MODERNA BOOSTER SHOT STILL AS OF TODAY 09/28/2021 ACCORDING TO THE MORNING NEWS AND ONLINE THE MODERNA BOOSTER 3RD SHOT HAS NOT YET BEEN APPROVED BY THE FDA OR THE CDC SO HOW IS PHARMACY SCHEDULING AND GIVING THE MODERNA BOOSTER?
This spontaneous case reported by a consumer, describes the occurrence of myalgia (sore arm) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient had myalgia (sore arm). At the time of the report, myalgia (sore arm) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
sore/Injection site pain; This is Spontaneous report from a non-contactable Pharmacist. This Pharmacist reported similar events for herself and 1 patient. This is a 2nd of Two reports. This report included that a 68-year-old male patient who received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number and expiry date was unknown), via an unspecified route of administration first dose on 17Jan2021 and second dose on 05Feb2021(Age at vaccination was 68-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. On an unknown date patient experienced sore/Injection site pain. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021130209 Same reporter/drug/similar event, different patient
guillain barre syndrome; Initial information was received on 26-Feb-2021 regarding an unsolicited valid serious case received from a consumer/non-health care professional via media.  This case involves patient (age and gender unspecified) who had Guillain Barre-syndrome, after he/she received INFLUENZA VACCINE.  Past medical treatment(s), vaccination(s) concomitant medication and family history were not provided.  The patient had no medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious Guillain Barre-syndrome (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will be no information available on the batch number for this case.; Sender's Comments: This case concerns patient (age and gender unspecified) who had Guillain barre-syndrome after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. Additional information regarding patient's past medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Information has been received from a registered pharmacist concerning a 52 year old female patient with type II diabetes mellitus and a history of Guillain-Barre syndrome, depression who was vaccinated with two 3-dose series of RECOMBIVAX HB. Concomitant therapy included AVANDAMET, WELLBUTRIN and AVALIDE. The patient has not responded to the vaccine. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been received which stated that patient was vaccinated with 4 doses of RECOMBIVAX HB (previously reported as 5 doses) on 31-JUL-2006 (Lot # "9510701"), 05-SEP-2006 (Lot # 653786/0185F), 21-FEB-2007 (Lot # "AUBVB287AA") and 26-APR-2007 (Lot # "AHBVB287AA"). It was also reported that patient had negative titers on 20-APR-2007 and 25-JUN-2007. Additional information has been requested.
Woke up at 2 AM with shivering, fever, massive headache and shoulder and knee joint pain.
Following the vaccine, patient developed fever and chest pain He was seen in the emergency department on 12/2 and again on 12/3. He was on Motrin and colcicene. He was diagnosed with myocarditis
2 weeks after getting Shingrix #1, burning & tingling in legs (right mostly) next 1 1/2 yrs spread to hands & feet
lump at the injection site; it is swollen at the injection site; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (it is swollen at the injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 30-Mar-2021, the patient experienced VACCINATION SITE MASS (lump at the injection site) and VACCINATION SITE SWELLING (it is swollen at the injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 30-Mar-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (lump at the injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (it is swollen at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
pt recvd MMR vax 6SEP91 & on 12SEP91 devel fever of 102; On 15SEP91 devel rash; these sx were also accompanied by irritability;
Patient was supposed to get moderna first dose but instead received moderna booster dose (0.25mL)
Caller relays she is 83 years old and had many other vaccines and had no reaction besides her arm would hurt and that was it.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 83-year-old female patient received BNT162b2 (BNT162B2), on 13Jan2021 as dose 1, single (Batch/Lot number: unknown), in arm, on 04Feb2021 as dose 2, single (Lot number: EM9810), in arm and on 30Sep2021 as dose 3 (booster), single (Lot number: 30135BA) at the age of 82 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Bronchitis", start date: Feb2022 (unspecified if ongoing); "High blood pressure diagnosed years ago" (unspecified if ongoing); "Diabetes" (unspecified if ongoing), notes: Patient was prediabetic for a long time and now on medication for this for the last 6 months. Concomitant medication(s) included: TYLENOL. Vaccination history included: Flu vaccine (Normal flu vaccine, patient has a sore arm.). The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Caller relays she is 83 years old and had many other vaccines and had no reaction besides her arm would hurt and that was it.". Relevant laboratory tests and procedures are available in the appropriate section. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  Additional information: Concomitant medications: Patient stated that she had just her daily medications. Declines to list.; Sender's Comments: Linked Report(s) : PFIZER INC-202200712728 similar report from same reporter
new pt was dishonest   said needed her booster   her covid card had her first two vax last dated 3/21   I gave the booster   when i processed ins said too soon  had booster in oct...   called pt she said her daughter is a physician and told her to get another
t104 w/in 24 hrs of vax lasting until 0800 next AM; t102 @ 0800 t101.4 time of visit 25APR92; pt also irritable & cranky & limp;
sore arm; rash is still there, spread across body; became hard to breathe went to urgent care; arm flared up, got hives at injection site; A spontaneous report was received from a Consumer concerning a 26-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, arm flared up, got hives at injection site, went to urgent care, became hard to breathe, rash is still there, spread across body.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.   on unknown date the patient experienced events sore arm, arm flared up, got hives at injection site, went to urgent care, became hard to breathe, rash is still there, spread across body.  Treatment details included Benadryl  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, sore arm, On an unknown date the outcome of events, arm flared up, On an unknown date the outcome of events, got hives at injection site, On an unknown date the outcome of events, went to urgent care, On an unknown date the outcome of events, became hard to breathe, On an unknown date the outcome of events, rash is still there, On an unknown date the outcome of events, spread across body was not reported.
patient reported experienced increased blood pressure as high as 200/100 within 15 min of any vaccine administration. Blood pressure increased in the past after flu vaccine and shingles vaccine. advised  by PCP to double dose of blood pressure medication on day  of vaccine. advised by PCP to receive third dose of COVID vaccine due to weakened immune system (SLE).   patient experiencing bad headache, dizzy, nauseous within 10 min of vaccine administration, COVID vaccine administered at 1:13pm.      1:22pm BP 151/52, pulse 65 bpm, head pounding    1:34 pm BP 187/76, Pulse 68bpm O2 sat 100%, headache    1:45pm BP 180/67, Pulse 64, headache improving   Patient declined EMS call and states this always happens and she will go home and rest.
Developed dizziness, generalized myalgias, fatigue, and abdominal discomfort approx one day after receiving vaccine. Seen at urgent care clinic on day #2 of symptoms
flu-like symptoms; could hardly walk; chills; had fever; extreme tiredness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), GAIT DISTURBANCE (could hardly walk), CHILLS (chills), PYREXIA (had fever) and FATIGUE (extreme tiredness) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN for Diabetes, LORATADINE (CLARITINE) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.  On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), GAIT DISTURBANCE (could hardly walk), CHILLS (chills), PYREXIA (had fever) and FATIGUE (extreme tiredness).   At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), GAIT DISTURBANCE (could hardly walk), CHILLS (chills), PYREXIA (had fever) and FATIGUE (extreme tiredness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Rather than drawing 20 doses, they drew 24 doses and administered those 24 doses today 10Nov2021.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Rather than drawing 20 doses, they drew 24 doses and administered those 24 doses today 10Nov2021.) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On 10-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTRATION ERROR (Rather than drawing 20 doses, they drew 24 doses and administered those 24 doses today 10Nov2021.). On 10-Nov-2021, PRODUCT ADMINISTRATION ERROR (Rather than drawing 20 doses, they drew 24 doses and administered those 24 doses today 10Nov2021.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not provided.
Pt came to our office on 11/6/2018 complaining of a knot on right upper arm after receiving a Hep A vaccine at work. It was a 3cmx3cm red, warm area on her right, lateral arm, 2 inches below the acromial process. We treated her with  mupirocin ointment and drained the infection from the site. We sent fluid for culture but nothing grew from it. She was then rx'd bactrim ds, prednisone, and methylprednisolone from the doctor who ran the immunization clinic.
7 months after vaccine, I had another reaction and was bed ridden for 2 days. I had a metallic taste again and was bed ridden for 2 days. I went to Hospital, they ran an ultrasound on my right leg and discovered I had deep Vein Thrombosis in my thighs. Blood work was taken along with a CT of my lung. I was hospitalized from 10/4/2021-10/7/2021
about 12 hours after the shot i was very achy and threw up once, I felt like I had the flu. I had a small fever and was very cold. A couple of days after that I developed a rash starting in the middle of my neck and went around my chest on one side.
Pain at site of injection (right arm); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01Jun2021 (Lot number: EWO171) at the age of 17 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 01Jun2021, outcome "not recovered", described as "Pain at site of injection (right arm)". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with COVID-19, since the vaccination, patient has not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
Nausea vomiting 101 temp for 6 hours ... then clear and lethargic 4 hrs  then back to normal . Slight soreness in arm ( much less than with  first shot )
Several hours after receiving the vaccine, patient developed a swollen tongue and was admitted over night to the hospital for observation.
severe chills; joint pain; headache for 10 straight days; sweating; fatigue; muscle weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included disorder thyroid (Thyroid disease). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 22:00, the patient experienced severe chills, joint pain, headache for 10 straight days, sweating, fatigue, muscle weakness. The patient did not receive any treatment for the events. The clinical outcome of events severe chills, joint pain, sweating, fatigue, muscle weakness recovered on an unspecified date in 2021. Headache recovered on 30Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse concerning a 13 year old female who on 26-AUG-2008 was vaccinated with her first dose of GARDASIL 0.5 ml, IM. The patient received her second dose of GARDASIL 0.5 ml, IM on 2-NOV-2008 and her third dose of GARDASIL 0.5 ml, IM on 3-MAR-2009. She mentioned she had not had a menstrual period "since my last dose of vaccine". Her last menstrual period was "at the end of November 2008". A urine pregnancy test performed in the office on 3-MAR-2009 was negative. A serum pregnancy test had been ordered but the results were pending. The patient's absence of period persisted. Additional information has been requested.
Awoke 9/12/09 with chills & sluggishness.  9/13/09 in AM noted arm red & swollen @ injection site L arm with swollen lymph nodes in L axilla.  Pt. felt better 9/14/09 AM but went to see PCP.  L arm noted to be red down to the elbow with red wheals @ injection site in L deltoid area.  Received shot of methylprednisone & oral course of prednisone.  Pt to return in 1 week for follow-up.  9/23 had flu - recovered without issues.
This spontaneous report as received from a healthcare professional refers to a 13-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 10-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
I began having full body hives 7 days after receiving first Moderna vaccine.  I am still experiencing hives as of this date.  I also experienced brain fog; however not sure if brain fog was a result of vaccine or the steroids and anti-histamines given to try and reduce hives.  I am no longer experiencing brain fog.   Anti-histamine treatment of hives is also now causing severe sedation which was not the norm prior to getting this vaccine.
Patient presented with complaints of  mild left local injection site pain at the site, but also anxiety, chest pain, shortness of breath, tingling and flushing.